Loyal
Latest round
- Series C
Last raised
- Feb 2026
Total raised
- $100M
Investors
- 2
About Loyal
Loyal is a company that specializes in veterinary pharmaceutical development, contributing to canine health with a focus on longevity. Founded in 2020, the company is headquartered in San Francisco, US.Loyal Animal Health, Inc. primarily focuses on developing innovative pharmaceutical solutions aimed at extending the healthy lifespan of dogs, particularly through their flagship product, LOY-002. This product is designed to function as an anti-aging pill, targeting various health issues commonly faced by senior dogs to improve their quality of life and longevity. The company is actively conducting clinical trials to validate the efficacy of LOY-002, with the first dog, named Boo, already dosed in their pivotal study. Loyal’s offerings also include LOY-001 and LOY-003, which cater to specific demographics of large dogs.Loyal Animal Health generates revenue through a combination of direct-to-consumer sales and partnerships with veterinary clinics and pet health organizations. The revenue structure includes the distribution of LOY-002 and other products via licensed veterinarians who prescribe them to pet owners, thereby ensuring a direct line of communication between the company and its end users. This transactional framework facilitates a streamlined experience for customers seeking longevity solutions for their pets. Pricing strategies for individual products have been developed to reflect the unique benefits and research backing each offering, enhancing customer willingness to invest in their dogs' health. The company plans to introduce new products that enhance canine health, alongside a targeted expansion into new markets in North America and Europe. This strategic development aims to improve access to their innovative health solutions for a broader audience of pet owners and veterinary professionals.
Who invested in Loyal
2 investors across 1 round
See all investors in Loyal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Feb 11, 2026
Amount
$100M
Investors
Questions about Loyal
Who invested in Loyal?
Loyal has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Loyal raised?
Loyal has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Loyal last raise money?
Loyal's most recent round on record is a Series C, in Feb 2026.
What does Loyal do?
Loyal is a company that specializes in veterinary pharmaceutical development, contributing to canine health with a focus on longevity.
Where is Loyal headquartered?
Loyal is headquartered in San Francisco, US.
Which VCs invest in companies like Loyal?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Loyal's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Loyal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.